Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor

Cervical cancer is one of the most common cancers in women. The development of new therapies with immune checkpoint inhibitors (ICIs) is being investigated for cervical cancer; however, their efficacy is not currently sufficient. Oncolytic virus therapy can increase tumor immunogenicity and enhance...

Descripción completa

Detalles Bibliográficos
Autores principales: Kagabu, Masahiro, Yoshino, Naoto, Murakami, Kazuyuki, Kawamura, Hideki, Sasaki, Yutaka, Muraki, Yasushi, Baba, Tsukasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916424/
https://www.ncbi.nlm.nih.gov/pubmed/36768352
http://dx.doi.org/10.3390/ijms24031988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916424/
https://www.ncbi.nlm.nih.gov/pubmed/36768352
http://dx.doi.org/10.3390/ijms24031988

Ejemplares similares